World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
32168
World Ranking
7753
National Ranking
4039

Overview

Edwin P. Alyea is affiliated with Harvard University in the United States and specializes primarily in the field of Medicine. Their research encompasses several subfields with a strong focus on Hematology, Genetics, Oncology, Immunology, and Public Health, Environmental and Occupational Health. The scientist's work predominantly centers around topics such as Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and Acute Lymphoblastic Leukemia research.

Their publication record includes contributions to major academic journals with repeated appearances in Blood Advances, Transplantation and Cellular Therapy, Blood, Biology of Blood and Marrow Transplantation, and UNC Libraries. These venues collectively highlight the scientist's involvement in studies related to hematologic malignancies and transplantation science.

Recent publications authored or co-authored by Edwin P. Alyea include:

  • Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial, 2021, Transplantation and Cellular Therapy
  • Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide, 2021, Blood Advances
  • Survival following allogeneic transplant in patients with myelofibrosis, 2020, Blood Advances
  • A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation, 2020, Blood
  • Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML, 2022, Blood

Edwin P. Alyea's frequent collaborators include Robert J. Soiffer, Vincent T. Ho, Haesook T. Kim, Corey Cutler, and Mitchell E. Horwitz, reflecting interdisciplinary cooperation within hematology and transplantation research. These coauthors have contributed to multiple joint projects, with collaboration counts ranging from 16 to 25 publications.

Best Publications

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

    Philippe Armand;Haesook T. Kim;Brent R. Logan;Zhiwei Wang

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

  • Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    Bart L. Scott;Marcelo C. Pasquini;Brent R. Logan;Juan Wu

  • Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

    Emmanuel Zorn;Haesook T. Kim;Haesook T. Kim;Stephanie J. Lee;Stephanie J. Lee;Blair H. Floyd;Blair H. Floyd

  • Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

    David B. Miklos;David B. Miklos;Haesook T. Kim;Haesook T. Kim;Katherine H. Miller;Katherine H. Miller;Luxuan Guo;Luxuan Guo

  • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho

  • Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

    Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug

  • Rituximab for steroid-refractory chronic graft-versus-host disease.

    Corey Cutler;David Miklos;Haesook T. Kim;Nathaniel Treister

  • Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

    Rafael Bejar;Kristen E. Stevenson;Bennett Caughey;R. Coleman Lindsley

  • Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma

    Arnold S. Freedman;Donna Neuberg;Peter Mauch;Robert J. Soiffer

  • Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

    Christopher J Gibson;R Coleman Lindsley;Vatche Tchekmedyian;Brenton G Mar

  • Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

    Martha Wadleigh;Paul G. Richardson;David Zahrieh;Stephanie J. Lee

  • Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

    Edwin P. Alyea;Robert J. Soiffer;Christine Canning;Donna Neuberg

  • A disease risk index for patients undergoing allogeneic stem cell transplantation

    Philippe Armand;Christopher J. Gibson;Corey Cutler;Vincent T. Ho

  • CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

    Asad Bashey;Asad Bashey;Bridget Medina;Sue Corringham;Mildred Pasek

  • Double unrelated reduced-intensity umbilical cord blood transplantation in adults

    Karen K. Ballen;Thomas R. Spitzer;Beow Y. Yeap;Steven McAfee

  • Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

    Edwin P Alyea;Edwin P Alyea;Haesook T Kim;Haesook T Kim;Vincent T Ho;Vincent T Ho;Corey Cutler;Corey Cutler

  • Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

    Stefanie Sarantopoulos;Kristen E. Stevenson;Haesook T. Kim;Corey S. Cutler

  • Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

    Christopher S. Hourigan;Laura W. Dillon;Gege Gui;Brent R. Logan

Frequent Co-Authors

Robert J. Soiffer
Robert J. Soiffer Harvard University
Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Vincent T. Ho
Vincent T. Ho Harvard University
Corey Cutler
Corey Cutler Harvard University
Jerome Ritz
Jerome Ritz Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Philippe Armand
Philippe Armand Harvard University
Catherine J. Wu
Catherine J. Wu Harvard University
Donna Neuberg
Donna Neuberg Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medical studies in the USA but prefer alternative pathways or need flexible learning options, there are several related online degree programs to consider. Many students explore nursing, as it remains a highly in-demand field. For those seeking a quicker entry into the profession, adn programs (Associate Degree in Nursing) offer a streamlined route to becoming a registered nurse, often taking just two years.

Those looking for non-clinical roles can consider medical billing and coding. With plenty of remote opportunities, you have access to financial aid for medical billing and coding programs, making them more affordable and accessible.

If you already hold a bachelor’s degree and want to transition into nursing, there are absn programs that don't require teas exams, helping you fast-track your medical career without extra testing hurdles.

Administrative roles in healthcare are growing, too. If you aim to quickly move into healthcare leadership, consider a accelerated healthcare administration degree—a practical option that prepares graduates for management positions in a dynamic industry.

Best Scientists Citing Edwin P. Alyea

Trending Scientists

Recently Published Articles